• BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Rating of "Moderate Buy" from Brokerages

    来源: Buzz FX / 04 12月 2024 02:36:12   America/Chicago


    BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat December 4, 2024 Share Link copied to clipboard. Shares of BioCryst Pharmaceuticals, Inc.
    Read more...
分享